CHMP recommends approval of Roche's (ROG SW) for Gazyva/Gazyvaro for lupus nephritis

17 Oct 2025 - 11:31- Equities- Source: GlobeNewswire

SMISwitzerlandROGPharmaceuticalsPharmaceuticals (Group)Pharmaceuticals, Biotechnology & Life SciencesRoche Holding AGEquitiesSwiss Market IndexEU SessionEU Session

Subscribe Now to Newsquawk

Click here for a 1 week free trial

Newsquawk provides audio news and commentary for over 15,000professional traders and brokers worldwide. Services include: